Gene · 64798
Papers1,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mTOR signalling pathway in stem cell bioactivities and angiogenesis potential. | Cell Prolif | 2023 | 37156724 | PubTator, text mining | PubMed |
| Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses. | Eur Rev Med Pharmacol Sci | 2023 | 37140276 | PubTator, text mining | PubMed |
| Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of Apoptosis. | Mol Cancer Ther | 2023 | 37127876 | PubTator, text mining | PubMed |
| Primary and Immortalized Cultures of Human Proximal Tubule Cells Possess Both Progenitor and Non-Progenitor Cells That Can Impact Experimental Results. | J Pers Med | 2023 | 37108999 | PubTator, text mining | PubMed |
| Differential Early Mechanistic Frontal Lobe Responses to Choline Chloride and Soy Isoflavones in an Experimental Model of Fetal Alcohol Spectrum Disorder. | Int J Mol Sci | 2023 | 37108779 | PubTator, text mining | PubMed |
| Placental Remote Control of Fetal Metabolism: Trophoblast mTOR Signaling Regulates Liver IGFBP-1 Phosphorylation and IGF-1 Bioavailability. | Int J Mol Sci | 2023 | 37108437 | PubTator, text mining | PubMed |
| Targeting neddylation as a novel approach to lung cancer treatment (Review). | Int J Oncol | 2023 | 37083098 | PubTator, text mining | PubMed |
| Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. | Nat Cancer | 2023 | 37081258 | PubTator, text mining | PubMed |
| ZDHHC2-Mediated AGK Palmitoylation Activates AKT-mTOR Signaling to Reduce Sunitinib Sensitivity in Renal Cell Carcinoma. | Cancer Res | 2023 | 37078777 | PubTator, text mining | PubMed |
| High-Intensity interval training reduces transcriptomic age: A randomized controlled trial. | Aging Cell | 2023 | 37078430 | PubTator, text mining | PubMed |
| Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases. | Front Endocrinol (Lausanne) | 2023 | 37077349 | PubTator, text mining | PubMed |
| Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. | Biomark Res | 2023 | 37069649 | PubTator, text mining | PubMed |
| DEPTOR as a novel prognostic marker inhibits the proliferation via deactivating mTOR signaling pathway in gastric cancer cells. | Exp Cell Res | 2023 | 37054772 | PubTator, text mining | PubMed |
| Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. | Molecules | 2023 | 37049920 | PubTator, text mining | PubMed |
| Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting. | Int J Mol Sci | 2023 | 37047427 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma. | Int J Mol Sci | 2023 | 37047267 | PubTator, text mining | PubMed |
| Potential Pathogenic Impact of Cow's Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma. | Int J Mol Sci | 2023 | 37047075 | PubTator, text mining | PubMed |
| Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors. | Cancers (Basel) | 2023 | 37046703 | PubTator, text mining | PubMed |
| The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms. | Nucleic Acids Res | 2023 | 37026479 | PubTator, text mining | PubMed |
| Tumor necrosis factor α-induced protein 3 mediates inflammation and neuronal autophagy in Parkinson's disease via the NFκB and mTOR pathways. | Neurosci Lett | 2023 | 37019273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64798/papers?page=9